Clinical trials in nuclear medicine. Sorted by date of last update.
Comparing Retreatment of Lu-177-DOTATATE PRRT versus Everolimus in Patients with Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT Trial
Phase 2
Last update: June 19
Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used with Targeted Radiation-based Treatment (Lutetium Lu-177 Dotatate), Compared to Lutetium Lu-177 Dotatate Alone for Metastatic Neuroendocrine Tumors
Lu-177-DOTA-EB-TATE in Adult Patients with Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
Phase 1
Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients with Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH
Phase 4
Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones
Cabazitaxel +/- Carboplatin vs Lu-177-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer (CATCH-177)
Last update: June 18
PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism
Phase N/A
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu-177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Lu-177-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) with Bone Marrow Involvement and Cytopenia
Last update: June 17
Post Marketing Study on Pluvicto in Korea